2021
DOI: 10.1016/j.cca.2021.01.014
|View full text |Cite
|
Sign up to set email alerts
|

Serum apelin-13 and risk of death following severe traumatic brain injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…Moreover, serum apelin-13 can serve as a prognostic biomarker to determine the severity of brain trauma. A study demonstrated that the serum concentration of apelin-13 was significantly lower in post-traumatic patients and correlated with trauma severity assessed alongside the Glasgow Coma Scale (GCS) [132].…”
Section: Apelinmentioning
confidence: 99%
“…Moreover, serum apelin-13 can serve as a prognostic biomarker to determine the severity of brain trauma. A study demonstrated that the serum concentration of apelin-13 was significantly lower in post-traumatic patients and correlated with trauma severity assessed alongside the Glasgow Coma Scale (GCS) [132].…”
Section: Apelinmentioning
confidence: 99%
“…A clinical study on 126 patients with severe TBI and 126 healthy controls found that lower serum level of apelin-13 in the patients correlated significantly with increased severity of TBI, and was an independent predictor of short-term mortality, indicating that serum apelin-13 is a promising prognostic biomarker for severe TBI ( Zhuang et al, 2021 ). The protective effects of apelin-13 in TBI are associated with inhibition of autophagy ( Bao et al, 2015 ), suppression of neuronal apoptosis through the GLP-1R/PI3K/Akt signaling ( Liu et al, 2019 ), and mitigation of blood-brain barrier (BBB) destruction and brain edema ( Bao et al, 2016a ).…”
Section: Apelin-13mentioning
confidence: 99%
“…Under severe traumatic brain injury (TBI), endogenous apelin-13 is depleted, and reduced serum apelin-13 concentration is negatively correlated with the disease and independently related to the mortality within 30 days [ 47 ]. The course of TBI can be divided into primary injury and secondary injury, and the changes of biomarkers and drug treatment are generally concentrated in the secondary injury stage.…”
Section: Apelin/apj System Inhibits Traumatic Brain Injurymentioning
confidence: 99%
“…In a series of cerebrovascular diseases, apelin has also demonstrated neuroprotective capabilities similar to those of biochemical experiments. Serum apelin-13 concentrations in patients with ischemic stroke are strongly associated with disability and mortality [ 47 ]. Patients with high apelin-13 levels had a lower incidence of stroke over one year [ 117 ].…”
Section: Clinical Application Of Apelin/apj System In Nervous Systemmentioning
confidence: 99%